ALB and cancer: Some indicators of systemic inflammation and nutrition status have also been reported to be useful in predicting the therapeutic prognosis of malignant tumors, such as the neutrophil/lymphocyte ratio, the C‐reactive protein/albumin ratio, and the platelet/hemoglobin ratio, that can be easily measured with conventional devices.19, 20